Universitätsklinikum Bonn (UKB), one of Germany’s leading university hospitals, combines excellence in medicine and research with outstanding teaching. Each year, more than half a million patients receive outpatient and inpatient care at the UKB. Around 3,500 students are enrolled in medicine and dentistry, and more than 600 individuals are trained annually in healthcare professions. With approximately 9,900 employees, the UKB is the third-largest employer in the Bonn/Rhein-Sieg region.
In the FOCUS-Klinikliste, the UKB ranks first among university hospitals in North Rhine-Westphalia and has the second-highest case-mix index among university hospitals nationwide. In 2024, the UKB acquired nearly €100 million in third-party funding for research, development, and teaching. The F.A.Z.-Institut recognized the UKB for the fourth consecutive year as “Germany’s Training Champion” and “Germany’s Most Desirable Employer.”
At the Institute of Clinical Chemistry and Clinical Pharmacology of the University Hospital Bonn, the following part-time position (65%) is to be filled at the earliest possible date:
We are committed to diversity and equal opportunities. Our aim is to increase the proportion of women in areas where they are underrepresented and to specifically promote their career development. We therefore strongly encourage suitably qualified women to apply. Applications will be considered in accordance with the State Equal Opportunities Act. Applications from suitably qualified persons with a certified severe disability and those with equivalent status are particularly welcome.
In the FOCUS-Klinikliste, the UKB ranks first among university hospitals in North Rhine-Westphalia and has the second-highest case-mix index among university hospitals nationwide. In 2024, the UKB acquired nearly €100 million in third-party funding for research, development, and teaching. The F.A.Z.-Institut recognized the UKB for the fourth consecutive year as “Germany’s Training Champion” and “Germany’s Most Desirable Employer.”
At the Institute of Clinical Chemistry and Clinical Pharmacology of the University Hospital Bonn, the following part-time position (65%) is to be filled at the earliest possible date:
2 international shared PhD positions (65%) - double PhD program between Osaka/Japan and Bonn/Germany (m/w/d)
Activities and responsibilities
A) Regulation of transcription during immune activation. How DNA elements fine tune immune cells function and activation (Paeschke group Bonn (www.paeschkelab.de)),and Matsuoka-Nakamura group at iFREC Osaka (https://www.ifrec.osaka-u.ac.jp/en/laboratory/yumi_matsuoka/index.htm))
B) Molecular mechanisms of immune activation by endogenous retroelements. (https://www.ukbonn.de/ikckp/forschung/ag-behrendt/) and the Arase group at iFREC Osaka (https://www.ifrec.osaka-u.ac.jp/en/laboratory/hisashi_arase/)
The program is based at two world-leading centers for immunological research: the Immunology Frontier Research Center (IFReC- https://www.ifrec.osaka-u.ac.jp) at Osaka University, which is recognized globally as one of the leading institutions in this field, and the ImmunoSensation Cluster of Excellence at the University of Bonn (https://www.immunosensation.de). Through joint program, we aim to create an exceptional interdisciplinary training environment for young scientists. Both students will benefit from access to state-of-the-art technologies, mentorship from world-leading experts-including leading scientists in the field of innate and adaptive immunity-and a clear translational perspective that bridges basic research and clinical application.
Both PhD students will be admitted to a newly established 4- year jointly supervised double degree PhD program between the University of Bonn and the Graduate School of Medicine at the University of Osaka. As part of this dual supervision it is mandatory that both students will stay one full year in the partner lab.
B) Molecular mechanisms of immune activation by endogenous retroelements. (https://www.ukbonn.de/ikckp/forschung/ag-behrendt/) and the Arase group at iFREC Osaka (https://www.ifrec.osaka-u.ac.jp/en/laboratory/hisashi_arase/)
The program is based at two world-leading centers for immunological research: the Immunology Frontier Research Center (IFReC- https://www.ifrec.osaka-u.ac.jp) at Osaka University, which is recognized globally as one of the leading institutions in this field, and the ImmunoSensation Cluster of Excellence at the University of Bonn (https://www.immunosensation.de). Through joint program, we aim to create an exceptional interdisciplinary training environment for young scientists. Both students will benefit from access to state-of-the-art technologies, mentorship from world-leading experts-including leading scientists in the field of innate and adaptive immunity-and a clear translational perspective that bridges basic research and clinical application.
Both PhD students will be admitted to a newly established 4- year jointly supervised double degree PhD program between the University of Bonn and the Graduate School of Medicine at the University of Osaka. As part of this dual supervision it is mandatory that both students will stay one full year in the partner lab.
Qualification profile
- We are seeking for two highly motivated PhD candidate to work at the interface of molecular Immunology, Biochemistry, and Molecular Biology. Both projects combine cell based in vitro and in vivo assays with advanced imaging techniques and state-of-the-art genome wide mapping tools to provide a complete picture.
- The applicant should hold a master degree (e.g. cell/molecular biology, genetics, immunology or biochemistry). Weparticularly look for applicants with a collaborative attitude towards research and who can combine high personal ambition and work ethics with eagerness to contribute to other projects.
We offer
- Responsible and diverse: A position with a high degree of creative freedom within a collaborative team
- Remuneration in accordance with TV-L: Collective agreement-based salary including annual special payment and occupational pension scheme
- Flexible for families: Flexible working time models, possibility of a place in the company daycare center, and support for employees returning from parental leave
- Smart commute: Excellent connection to the SWB public transport network and the option of an interest-free loan for purchasing an e-bike
- Supported professional development: Individual development opportunities through courses, e-learning, and coaching
- Structured start: Comprehensive and structured onboarding process
- Healthy workplace: Numerous health promotion offers and free membership at the UKB fitness studio
- Employee benefits: Discounted offers for employees (corporate benefits program)
We are committed to diversity and equal opportunities. Our aim is to increase the proportion of women in areas where they are underrepresented and to specifically promote their career development. We therefore strongly encourage suitably qualified women to apply. Applications will be considered in accordance with the State Equal Opportunities Act. Applications from suitably qualified persons with a certified severe disability and those with equivalent status are particularly welcome.
Complete applications in English should include a CV, a one page maximum statement of research experiences and interests andaddresses of two referees. Please submit your application as a single pdf file with a note for project A or B
Application closing date: 30th of March 2026.
Prof. Dr. rer. Katrin Paeschke
Institute of Clinical Chemistry and Clinical Pharmacology
University Hospital Bonn
Venusberg-Campus-1
53127 Bonn
email
Application closing date: 30th of March 2026.
Prof. Dr. rer. Katrin Paeschke
Institute of Clinical Chemistry and Clinical Pharmacology
University Hospital Bonn
Venusberg-Campus-1
53127 Bonn
Bitte beziehe dich bei deiner Bewerbung auf jobvector
Für diesen Job einen passenden Lebenslauf erstellen und direkt bewerben
Lebenslauf erstellen
